Trial Details
COMPLETEDBasic Information
| Clinical ID | c4007 |
|---|---|
| Identifier | NCT01190410 |
| Trial Title | Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: certolizumab pegol|DRUG: certolizumab pegol |
Participant Information
| Sponsor | UCB Pharma |
|---|---|
| City | Orange |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2010-08 |
|---|---|
| Primary Completion Date | 2017-11-27 |
| Completion Date | 2017-11-27 |